Australia markets closed

Revive Therapeutics Ltd. (RVVTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0200+0.0010 (+5.26%)
At close: 02:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,747
3,583
15,156
6,705
455.089
Selling general and administrative
1,612
1,773
2,492
11,547
3,091
Total operating expenses
3,512
5,521
17,833
18,592
3,684
Operating income or loss
-3,512
-5,521
-17,833
-18,592
-3,684
Interest expense
32.707
43.997
63.423
78.982
87.656
Total other income/expenses net
-
-864.5
-26.701
-1,544
-1,656
Income before tax
-4,298
-6,321
-17,807
-20,119
-5,382
Income from continuing operations
-4,298
-6,321
-17,807
-20,119
-5,382
Net income
-4,298
-6,321
-17,807
-20,119
-5,382
Net income available to common shareholders
-4,298
-6,321
-17,807
-20,119
-5,382
Basic EPS
-0.01
-0.02
-0.06
-0.08
-0.05
Diluted EPS
-0.01
-0.02
-0.06
-0.08
-0.05
Basic average shares
347,740
339,371
319,764
267,491
106,878
Diluted average shares
347,740
339,371
319,764
267,491
106,878